Vestal Point Capital »

Arvinas Ord shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Arvinas Ord (ARVN) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Arvinas Ord

Tip: Access up to 7 years of quarterly data

All positions including Arvinas Ord held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arvinas Ord by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.6M 906k 10.60

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Arvinas Ord

Vanguard Group
BlackRock
Vanguard Portfolio Management
D. E. Shaw & Co
Pfizer
Vanguard Capital Management
TCG Crossover Management
Armistice Capital
State Street Corporation
Two Sigma Investments
Geode Capital Management
Jacobs Levy Equity Management
Qube Research & Technologies
Citadel Advisors
Federated Investors

View all funds holding Arvinas Ord